Cargando…
Random unstimulated pediatric luteinizing hormone levels are not reliable in the assessment of pubertal suppression during histrelin implant therapy
BACKGROUND: Gonadotropin-releasing hormone agonist (GnRHa)-stimulated luteinizing hormone (LH) is the standard hormonal assessment for both diagnosis and therapeutic monitoring of children with central precocious puberty (CPP). Use of unstimulated (random) LH levels may be helpful in diagnosis and h...
Autores principales: | Neely, E Kirk, Silverman, Lawrence A, Geffner, Mitchell E, Danoff, Theodore M, Gould, Errol, Thornton, Paul S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4220797/ https://www.ncbi.nlm.nih.gov/pubmed/24295437 http://dx.doi.org/10.1186/1687-9856-2013-20 |
Ejemplares similares
-
Results of a Second Year of Therapy with the 12-Month Histrelin Implant for the Treatment of Central Precocious Puberty
por: Rahhal, Samar, et al.
Publicado: (2009) -
Extended Use of Histrelin Implant in Pediatric Patients
por: Pine-Twaddell, Elyse, et al.
Publicado: (2023) -
SAT-298 A Case of a Forgotten Histrelin Acetate Implant: Can Histrelin Acetate Implants Be Used for More Than a Year?
por: KV Krishnaraj, Balasundari, et al.
Publicado: (2019) -
Histrelin Implantation and Growth Outcomes in Children With Congenital Adrenal Hyperplasia: An Institutional Experience
por: Swendiman, Robert A, et al.
Publicado: (2019) -
Gonadotropin Suppression for 7 Years After a Single Histrelin Implant for Precocious Puberty
por: Villalta, Douglas, et al.
Publicado: (2022)